2025 Q4
2025-10-14
Q3 Earnings + Orthopaedics Spinoff
Q3 2025 results + separating Orthopaedics business
View Filing →
2025 Q3
2025-09-09
Board Director Elected
John Morikis elected to Board, former Sherwin-Williams CEO
View Filing →
2025-07-16
Q2 2025 Earnings
Q2 ended June 29, 2025 results
View Filing →
2025 Q2
2025-06-10
Director Elected
Daniel Pinto (JPMorgan President) joins board July 1
View Filing →
2025-04-30
Director Retirement & Annual Meeting
D. Adamczyk retiring May 31, all 11 directors elected
View Filing →
2025-04-15
Q1 Earnings & Dividend Hike
Q1 2025 results + dividend increased 4.8% to $1.30/share (63rd consecutive year)
View Filing →
2025-04-03
Bankruptcy Plan Denied
$7B reserve reversal from Red River Talc bankruptcy denial
View Filing →
2025 Q1
2025-02-26
Euro Bond Offering
€4B notes across 5 tranches, 2.7%-3.7% coupons, 2029-2055 maturities
View Filing →
2025-02-20
Debt Offering
$5B notes issued, rates 4.5%-5.0%
View Filing →
2025-01-22
Q4 2024 Earnings
Q4 and full year 2024 results announced
View Filing →
2024 Q4
2024-10-15
Q3 Earnings
Q3 2024 results for period ended Sept 29
View Filing →
2024 Q3
2024-09-20
Talc Litigation Bankruptcy Settlement
$8B settlement via subsidiary Chapter 11 filing
View Filing →
2024-09-10
Director Retirement
D.S. Davis retired as Director, Audit Committee Chair transition to D. Adamczyk
View Filing →
2024-08-26
CHRO Retirement
Peter M. Fasolo retiring October 1, 2024
View Filing →
2024-07-17
Q2 Earnings
Q2 2024 results for period ended June 30, 2024
View Filing →
2024 Q2
2024-05-20
Multi-Tranche Debt Offering
$6B total: $4B USD notes (4.8-5.25%) + €2.5B EUR notes (3.2-3.55%)
View Filing →
2024-05-17
Completed Kenvue Divestiture
Exchanged remaining 182M Kenvue shares for $3.6B commercial paper
View Filing →
2024-05-01
Q1 Earnings + $6.5B Talc Settlement
EPS revised down from $2.20 to $1.34 due to $2.7B incremental talc charge
View Filing →
2024-04-29
Annual Shareholder Meeting & Bylaws Amendment
All 13 directors elected, bylaws updated for special meetings and proxy rules
View Filing →
2024-04-16
Q1 Earnings & Dividend Increase
Q1 2024 results released, dividend raised 4.2% to $1.24/share (62nd consecutive year)
View Filing →
2024 Q1